Drug recalls from US raise export concerns
Financial Express Kochi|December 17, 2024
THE RECENT DRUG recalls by US arms of Indian drugmakers have turned the spotlight back on quality issues faced by the domestic pharma companies in the lucrative export market.
MANU KAUSHIK

Currently, Aurobindo Pharma, Glenmark and Zydus are in the process of recalling their products in the US market due to manufacturing issues. While the concerns around Aurobindo Pharma and Glenmark Pharma pertain to the "deviation from the current good manufacturing practices (cGMP)", in the case of Zydus, wrong labelling is the reason for recall.

Experts said the recent instances of recall could impact the Indian pharma industry which is already facing the heat globally due to a spate of quality issues over the past two years.

この記事は Financial Express Kochi の December 17, 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Financial Express Kochi の December 17, 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

FINANCIAL EXPRESS KOCHIのその他の記事すべて表示
Trump tariff threats to open market access talks
Financial Express Kochi

Trump tariff threats to open market access talks

Experts call for a targeted reduction of levy by India, with policies to boost manufacturing

time-read
3 分  |
December 19, 2024
2W sales skid sharp 19% in Dec
Financial Express Kochi

2W sales skid sharp 19% in Dec

FIRST FALL IN TWO YEARS

time-read
1 min  |
December 19, 2024
Financial Express Kochi

H-1B overhaul a boon for Indian techies

THE US GOVERNMENT on Tuesday announced major reforms in its popular H-1B visa programme, a move that is expected to help thousands of Indian tech professionals, reports Manu Kaushik.

time-read
1 min  |
December 19, 2024
Sebi tightens SME listing regulations
Financial Express Kochi

Sebi tightens SME listing regulations

• Performance validation agency PaRRVA set up

time-read
2 分  |
December 19, 2024
Financial Express Kochi

Trump threatens to impose reciprocal tariffs on India

US PRESIDENT-ELECT DONALD Trump has said that India charges \"a lot\" of tariffs, reiterating his intention to impose reciprocal tariffs in retaliation for what New Delhi will impose on the import of certain American products.

time-read
2 分  |
December 19, 2024
Financial Express Kochi

'Had fun but it's time': Ashwin bows out of internationals with shock retirement call

RASHWIN STOOD in the corridor outside the press conference room after the third Test ended in a draw.

time-read
3 分  |
December 19, 2024
Financial Express Kochi

US announces H-1B visa overhaul, Indian techies to benefit

HOW THE MOVE WILL BENEFIT INDIA

time-read
2 分  |
December 19, 2024
Financial Express Kochi

Free healthcare for senior citizens: Kejriwal

AHEAD OF DELHI Assembly elections next year, AAP national convener and former CM Arvind Kejriwal announced that all citizens of Delhi aged above 60 will get free medical care in government and private hospitals if his party returns to power. The scheme, called Sanjeevani, will not have an income cap for eligibility, he said.

time-read
1 min  |
December 19, 2024
Financial Express Kochi

Navy boat hits ferry off Mumbai coast, 13 dead

A PRIVATE FERRY, carrying more than 110 passengers to Elephanta Island off Mumbai coast, capsized after a Navy speedboat crashed into it on Wednesday. At least 13 people were killed in the incident, officials said, adding that the rest have been rescued.

time-read
1 min  |
December 19, 2024
Financial Express Kochi

Sebi tightens SME IPO rules

SEBI also cleared the review of merchant bankers, custodians, and provisions for high-value debt-listed entities (HVDLE) by increasing the threshold for identification of HVDLE from ₹500 cr to ₹1,000 cr, aligning it with that of large corporates, and introduced a sunset clause governing corporate governance of debt-listed securities.

time-read
1 min  |
December 19, 2024